The Extracellular Matrix Regulates Cancer Progression and Therapy Response: Implications for Prognosis and Treatment

被引：36
作者：
Denys, Hannelore [2 ]
Braems, Geert [3 ]
Lambein, Kathleen [4 ]
Pauwels, Patrick [4 ]
Hendrix, An [2 ]
De Boeck, Astrid [1 ]
Mathieu, Veronique [5 ]
Bracke, Marc [1 ]
De Wever, Olivier [1 ]
机构：
[1] Ghent Univ Hosp, Dept Radiotherapy & Nucl Med, Lab Expt Canc Res, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Dept Med Oncol, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Dept Gynecol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Dept Pathol, B-9000 Ghent, Belgium
[5] Free Univ Brussels ULB, Inst Pharm, Toxicol Lab, Brussels, Belgium
来源：
CURRENT PHARMACEUTICAL DESIGN | 2009年 / 15卷 / 12期
关键词：
FOCAL ADHESION KINASE; CELL LUNG-CANCER; PROSTATE-SPECIFIC ANTIGEN; RESISTANCE CAM-DR; HEPARAN-SULFATE; GROWTH-FACTOR; INDUCED APOPTOSIS; BETA(1) INTEGRIN; GENE-EXPRESSION; STROMAL CELLS;
D O I：
10.2174/138161209787846711
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Emerging evidence points towards a key role of the extracellular matrix (ECM) during tumor progression and therapy resistance. Paradoxically, in today's routine of cancer management the ECM is not taken into account. It is the aim of the present review to broaden our understanding of the mechanisms of therapy resistance, taking the ECM as a presumptive central regulator. The stromal ecosystem drives the accumulation of ECM at the invasion front. Therefore, we address the question whether the detection of ECM signatures in histopathology and biofluids may help predicting therapy resistance and determining the prognosis of cancer. Since the ECM is an attractive target for tumor therapy, current therapeutic strategies in preclinical or clinical development will be discussed.
引用
收藏
页码：1373 / 1384
页数：12
相关论文
共 126 条
[81]   Tissue geometry determines sites of mammary branching morphogenesis in organotypic cultures [J].
Nelson, Celeste M. ;
VanDuijn, Martijn M. ;
Inman, Jamie L. ;
Fletcher, Daniel A. ;
Bissell, Mina J. .
SCIENCE, 2006, 314 (5797) :298-300
[82]   DDR2 receptor promotes AMP-2-mediated proliferation and invasion by hepatic stellate cells [J].
Olaso, E ;
Ikeda, K ;
Eng, FJ ;
Xu, LM ;
Wang, LH ;
Lin, HC ;
Friedman, SL .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) :1369-1378
[83]   p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop [J].
Ongusaha, PP ;
Kim, JI ;
Fang, L ;
Wong, TW ;
Yancopoulos, GD ;
Aaronson, SA ;
Lee, SW .
EMBO JOURNAL, 2003, 22 (06) :1289-1301
[84]   Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy [J].
Overall, CM ;
Kleifeld, O .
NATURE REVIEWS CANCER, 2006, 6 (03) :227-239
[85]   Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin [J].
Paganelli, G ;
Grana, C ;
Chinol, M ;
Cremonesi, M ;
De Cicco, C ;
De Braud, F ;
Robertson, C ;
Zurrida, S ;
Casadio, C ;
Zoboli, S ;
Siccardi, AG ;
Veronesi, U .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (04) :348-357
[86]   1-[4-(1H-benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors [J].
Pan, WT ;
Miao, HQ ;
Xu, YJ ;
Navarro, EC ;
Tonra, JR ;
Corcoran, E ;
Lahiji, A ;
Kussie, P ;
Kiselyov, AS ;
Wong, WC ;
Liu, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) :409-412
[87]   β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts [J].
Park, Catherine C. ;
Zhang, Hui J. ;
Yao, Evelyn S. ;
Park, Chong J. ;
Bissell, Mina J. .
CANCER RESEARCH, 2008, 68 (11) :4398-4405
[88]   β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo [J].
Park, CC ;
Zhang, H ;
Paravicini, M ;
Gray, JW ;
Baehner, F ;
Park, CJ ;
Bissell, MJ .
CANCER RESEARCH, 2006, 66 (03) :1526-1535
[89]   Tensional homeostasis and the malignant phenotype [J].
Paszek, MJ ;
Zahir, N ;
Johnson, KR ;
Lakins, JN ;
Rozenberg, GI ;
Gefen, A ;
Reinhart-King, CA ;
Margulies, SS ;
Dembo, M ;
Boettiger, D ;
Hammer, DA ;
Weaver, VM .
CANCER CELL, 2005, 8 (03) :241-254
[90]   Clinical significance of MMP-2 and MMP-9 in patients with oral cancer [J].
Patel, Beena P. ;
Shah, Shakuntala V. ;
Shukla, Shilin N. ;
Shah, Pankaj M. ;
Patel, Prabhudas S. .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (06) :564-572
45678910111213